Prialt Side Effects

Generic name: ziconotide

Medically reviewed by Drugs.com. Last updated on May 22, 2024.

Note: This document provides detailed information about Prialt Side Effects associated with ziconotide. Some dosage forms listed on this page may not apply specifically to the brand name Prialt.

Applies to ziconotide: intrathecal solution.

Important warnings This medicine can cause some serious health issues

Intrathecal route (solution)

Ziconotide is contraindicated in patients with a preexisting history of psychosis.

Severe psychiatric symptoms and neurological impairment may occur during treatment with ziconotide.

Monitor all patients frequently for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness.

Discontinue ziconotide therapy in the event of serious neurological or psychiatric signs or symptoms.

Serious side effects of Prialt

Along with its needed effects, ziconotide (the active ingredient contained in Prialt) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ziconotide:

More common side effects

• anxiety
• being forgetful
• change in walking and balance
• changes in patterns and rhythms of speech
• clumsiness or unsteadiness
• confusion
• decrease in the frequency of urination
• decrease in urine volume
• delusions
• dementia
• difficulty in passing urine (dribbling)
• difficulty with speaking
• feeling unusually cold
• painful urination
• problems with speech or speaking
• seeing, hearing, or feeling things that are not there
• shakiness and unsteady walk
• shakiness in the legs, arms, hands, or feet
• shivering
• slurred speech
• thoughts of killing oneself
• trembling or shaking of the hands or feet
• uncontrolled eye movements
• unsteadiness, trembling, or other problems with muscle control or coordination

Less common side effects

• aggressive or angry
• chest pain
• chills
• confusion as to time, place, or person
• convulsions
• cough
• dark-colored urine
• dizziness
• drowsiness
• fainting
• fast heartbeat
• fearfulness, suspiciousness, or other mental changes
• feeling that others are watching you or controlling your behavior
• feeling that others can hear your thoughts
• fever
• general feeling of illness
• holding false beliefs that cannot be changed by fact
• lightheadedness
• muscle spasm or jerking of all extremities
• muscle stiffness
• rapid, shallow breathing
• severe mood or mental changes
• shortness of breath
• sneezing
• sore throat
• stiff neck or back
• tightness in the chest
• troubled breathing
• trouble in concentration
• trouble in sleeping
• unusual behavior unusual excitement, nervousness, or restlessness
• unusual tiredness or weakness
• wheezing

Rare side effects

• actions that are out of control
• changes in behavior
• irritability
• talking, feeling, and acting with excitement

Incidence not known

• large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

Get emergency help immediately if any of the following symptoms of overdose occur while taking ziconotide:

Symptoms of overdose

• decreased awareness or responsiveness
• severe sleepiness

Other side effects of Prialt

Some side effects of ziconotide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• blurred vision
• crawling feelings
• diarrhea
• dizziness
• dizziness or lightheadedness
• excessive muscle tone, tension, or tightness
• feeling of constant movement of self or surroundings
• headache
• itching
• lack or loss of strength
• loss of appetite
• loss of memory
• nausea
• pain in the arms or legs
• problems with memory
• sensation of spinning
• sleepiness or unusual drowsiness
• vomiting
• weight loss

Less common side effects

• acid or sour stomach
• back pain
• bad, unusual, or unpleasant (after) taste
• belching
• bladder pain
• bloody or cloudy urine
• bruising
• change in taste
• congestion
• constipation
• continuing ringing or buzzing or other unexplained noise in the ears
• crying
• dehydration
• depersonalization
• depression
• difficulty seeing at night
• difficulty with moving
• double vision
• dry mouth
• dry skin
• dysphoria
• euphoria
• fainting
• frequent urge to urinate
• hearing loss
• heartburn
• hoarseness
• increased sensitivity of the eyes to sunlight
• increased sensitivity to pain or touch
• indigestion
• loss of bladder control
• loss of taste
• lung disorder
• nerve pain
• pain in the joints
• pain or tenderness around the eyes and cheekbones
• pale skin
• pounding in the ears
• quick to react or overreact emotionally
• rapidly changing moods
• red, scaly, swollen, or peeling areas of the skin
• redness or pain at the catheter site
• runny nose
• severe muscle stiffness
• shortness of breath or troubled breathing
• sleeplessness
• slow or fast heartbeat
• stomach discomfort, upset, or pain
• stuffy nose
• sweating
• swelling or redness in the joints
• tender, swollen glands in the neck
• tightness of the chest or wheezing
• trouble with swallowing
• unusual bleeding or bruising
• unusual tiredness or weakness
• voice changes
• warmth on the skin
• weakness or heaviness in the legs

Incidence not known

• burning sensation on the skin
• flaking and falling off of skin
• skin blisters
• sores on the skin

For healthcare professionals

Applies to ziconotide: intrathecal solution.

General adverse events

The most common reported adverse reactions have included dizziness, nausea, confusional state, and nystagmus.^[Ref]

Psychiatric

• Very common (10% or more): Confusional state (15%)
• Common (1% to 10%): Amnesia, memory impairment, anxiety, insomnia, agitation, cognitive disorder, depression, depression aggravated, disorientation, hallucination, hallucination auditory, hallucination visual, irritability, mood disorder, nervousness, paranoia
• Uncommon (0.1% to 1%): Suicide attempt
• Frequency not reported: Psychotic disorder, suicidal ideation^[Ref]

Psychotic disorder and suicide ideation occurred in less than 2% of patients; suicide attempt was reported in less than 1% of patients; these events were assessed by clinical investigators as related to drug therapy.^[Ref]

Nervous system

• Very common (10% or more): Dizziness, (40%), ataxia (14%), headache (13%), somnolence (17%)
• Common (1% to 10%): dysarthria, dysgeusia, nystagmus, tremor, aphasia, areflexia, balance impaired, burning sensation, coordination abnormal, disturbance in attention, dizziness postural, hypnoanesthesia, mental impairment, paresthesia, sedation, speech disorder
• Frequency not reported: Cerebrovascular accident, meningitis, stupor, loss of consciousness, clonic convulsion and grandmal convulsion^[Ref]

Cerebrovascular accident, meningitis, stupor, loss of consciousness, clonic convulsion and grandmal convulsion occurred in less than 2% of patients; these events were assessed by clinical investigators as related to drug therapy.^[Ref]

Musculoskeletal

• Very common (10% or more): Abnormal gait (14%)
• Common (1% to 10%): Muscle spasms, pain in limb, increased blood creatine phosphokinase, muscle cramp, muscle weakness, myalgia
• Frequency not reported: Rhabdomyolysis^[Ref]

Rhabdomyolysis occurred in less than 2% of patients and was assessed by clinical investigators as related to drug therapy^[Ref]

Immunologic

• Frequency not reported: Sepsis

Sepsis occurred in less than 2% of patients and was assessed by clinical investigators as related to drug therapy.

Gastrointestinal

• Very common (10% or more): Nausea (40%), diarrhea (18%), vomiting (16%)
• Common (1% to 10%): Abdominal pain, constipation, dry mouth, nausea aggravated^[Ref]

Dermatologic

• Common (1% to 10%): Pruritus, increased sweating
• Postmarketing reports: Hypersensitivity reactions including angioedema, serious skin reactions including bullous dermatitis, skin ulcers, skin exfoliation, and burning skin sensation^[Ref]

Hypersensitivity

• Postmarketing reports: Hypersensitivity reactions including angioedema, serious skin reactions including bullous dermatitis, skin ulcers, skin exfoliation, and burning skin sensation

Ocular

• Common (1% to 10%): Blurred vision, diplopia, visual disturbance^[Ref]

Cardiovascular

• Common (1% to 10%): Peripheral edema, hypotension, orthostatic hypotension
• Frequency not reported: Atrial fibrillation^[Ref]

Atrial fibrillation and abnormal electrocardiogram were reported in less than 2% of patient; these events were assessed by clinical investigators as related to drug therapy.^[Ref]

Metabolic

• Common (1% to 10%): Anorexia, decreased appetite^[Ref]

Respiratory

Respiratory distress occurred in less than 2% of patients; Fatal aspiration pneumonia was reported in less than 1% of patients; these were assessed by clinical investigators as related to drug therapy.^[Ref]

Respiratory side effects including bronchitis, increased cough, dyspnea, lung disorder, pharyngitis, pneumonia, rhinitis, and sinusitis have been reported in at least 2% of patients participating in the clinical trials. Respiratory distress has been reported in less than 2% of patients participating in the clinical trials. Fatal aspiration pneumonia has been reported in less than 1% of patients participating in clinical trials.^[Ref]

Other

• Very common (10% or more): Asthenia (18%)
• Common (1% to 10%): Vertigo, pyrexia, rigors, fall, fatigue, lethargy^[Ref]

Renal

Renal side effects including urinary retention (9%) have been reported. Urinary incontinence, urinary tract infection, and impaired urination have been reported in at least 2% of patients participating in the clinical trials. Acute kidney failure has been reported in less than 2% of patients participating in the clinical trials.^[Ref]

Acute renal failure occurred in less than 2% of patients and was assessed by clinical investigators as related to drug therapy.^[Ref]

Genitourinary

• Common (1% to 10%): Urinary retention, dysuria, urinary hesitation

Further information

Prialt side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer